Project Grant HT94252410090
Award Date 2/1/24
Completion Date 1/31/27
Dollars Obligated $1.6M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19104, USA
Similar Awards
- This Defense Health Agency (DHA) Project Grant award for $4,509,475.00, granted on Sep 15, 2023 under the Military Medical Research and Development program (CFDA 12.420), supports a 4-year research project titled "Optimizing a Surveillance Strategy to Tackle Breast Cancer Dormancy and Minimal Residual Disease" to be conducted by the Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania. The objective of this research is...
- The Trustees of the University of Pennsylvania will receive $975,000 through a three-year Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support lung cancer research from July 1, 2023 to June 30, 2026. Through this funding, the University and its Clinical Practices will conduct biomedical research to transform service member healthcare and investigate medical solutions applicable to battlefield medicine....
- The Trustees of the University of Pennsylvania were awarded a $1,624,578 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research into the mechanisms of mammary tumor recurrence from July 1, 2021 to June 30, 2024. Through this funding, the University of Pennsylvania will investigate medical solutions for breast cancer recurrence on the battlefield and for the American public...
- The Trustees of the University of Pennsylvania were awarded a $495,379 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research from September 2021 through September 2024 to target hepatocyte-derived factors in order to improve the efficacy of immunotherapy for pancreatic cancer. The Military Medical Research and Development program aims to transform health care for service members and the public...
- This federal Project Grant award for $1,178,136.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), is supporting research at the University of Pennsylvania to exploit the absence of TP53 mutations in epithelial ovarian cancer using next-generation p53-stabilizing agents. The research aims to transform healthcare for military service members, veterans, and the broader public through the development of innovative medical solutions...
- This Project Grant award of $1,625,000 from the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) supports in-vivo mechanistic characterization of the angiogenic immune checkpoint in liver cancer at the Trustees of the University of Pennsylvania. The research aims to advance scientific understanding and develop solutions for this important health challenge. The award commenced on September 1, 2023 and is scheduled for completion by August 31, 2027. As a...
- This $812,487 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research at the University of Pennsylvania to modulate liver inflammation and improve outcomes for pancreatic cancer patients. The three-year award, starting September 30, 2025, will fund specialized biomedical research to develop innovative medical solutions for military personnel and the broader public. The University of Pennsylvania, a leading...
- This $1,096,866 project grant was awarded on August 15, 2023 by the Defense Health Agency under the Department of Defense's Military Medical Research and Development program (CFDA 12.420). The grant, titled "TARGETING BRANCHED CHAIN AMINO ACIDS IN KIDNEY CANCER," will be carried out by The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, over a 3-year period ending on August 14, 2026. The funding supports biomedical...
- The Trustees of the University of Pennsylvania received a $568,256 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from August 1, 2021 to July 31, 2024 to examine the role of microenvironment mechanics in sarcoma immune evasion. Through the support of basic, applied, and advanced biomedical research, the Military Medical Research and Development program aims to transform...
- The Trustees of the University of Pennsylvania were awarded a $560,870 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research from September 2021 through September 2024 to target hepatocyte-derived factors in order to improve the efficacy of immunotherapy for pancreatic cancer. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the...